Cargando…
p27(Kip1) – p(RhoB)lematic in lung cancer
Lung cancer is the leading cause of cancer mortality worldwide, with adenocarcinomas of the non‐small cell lung carcinoma (NSCLC) subtype accounting for the majority of cases. Therefore, an urgent need exists for a more detailed dissection of the molecular events driving NSCLC development and the id...
Autores principales: | Podmirseg, Silvio R, Vosper, Jonathan, Hengst, Ludger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492176/ https://www.ncbi.nlm.nih.gov/pubmed/30549261 http://dx.doi.org/10.1002/path.5218 |
Ejemplares similares
-
The CDK inhibitor p57(Kip2) enhances the activity of the transcriptional coactivator FHL2
por: Kullmann, Michael Keith, et al.
Publicado: (2020) -
Inability to phosphorylate Y88 of p27(Kip1) enforces reduced p27 protein levels and accelerates leukemia progression
por: Jäkel, Heidelinde, et al.
Publicado: (2022) -
FLT3 and FLT3-ITD phosphorylate and inactivate the cyclin-dependent kinase inhibitor p27(Kip1) in acute myeloid leukemia
por: Peschel, Ines, et al.
Publicado: (2017) -
Cold-inducible RNA-binding protein (CIRP) induces translation of the cell-cycle inhibitor p27(Kip1)
por: Roilo, Martina, et al.
Publicado: (2018) -
Caspases uncouple p27(Kip1) from cell cycle regulated degradation and abolish its ability to stimulate cell migration and invasion
por: Podmirseg, S R, et al.
Publicado: (2016)